EUVIMEDEUVIMED entdecken
Crossref

Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?

Emily Kim, Sophia Shalhout, Howard Kaufman, Kevin Emerick, Vishal Patel, Khalid Garmen, Isaac Brownell, David Miller

Journal of Cutaneous Oncology · 2023

DOI: 10.59449/joco.2023.01.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2023. Verfasst von Emily Kim und 7 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, E., Shalhout, S., Kaufman, H., Emerick, K., Patel, V., Garmen, K., Brownell, I., & Miller, D. (2023). Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2023.01.09

Vancouver

Kim E, Shalhout S, Kaufman H, Emerick K, Patel V, Garmen K, et al. Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?. Journal of Cutaneous Oncology. 2023. doi:10.59449/joco.2023.01.09

BibTeX
@article{Kim2023,
  author = {Kim, Emily and Shalhout, Sophia and Kaufman, Howard and Emerick, Kevin and Patel, Vishal and Garmen, Khalid and Brownell, Isaac and Miller, David},
  title = {Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?},
  journal = {Journal of Cutaneous Oncology},
  year = {2023},
  doi = {10.59449/joco.2023.01.09}
}
Kostenlos starten →